Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

1p and 1q: Partners in crime in multiple myeloma.

View Full Paper
Ask AI
Bookmark
Share

Authors

SDSrinivas DevarakondaAVArti VaishnavQZQiuhong Zhao

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Devarakonda et al. (2024) studied this question.

synapsesocial.com/papers/68e67069b6db6435875fb221https://doi.org/10.1200/jco.2024.42.16_suppl.7571
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1P21 | THE LONG TERM PROGNOSTIC IMPACT OF CHROMOSOME 1 ABNORMALITIES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS2026
  2. 2Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and/or in main clone2025 · 3 citations
  3. 3Real-world poor prognostic impact of del(1p32) in newly diagnosed multiple myeloma among Asian populations2025
  4. 4Cytogenetics-based clinical trajectories of patients with MRD negativity post autologous stem cell transplant for multiple myeloma2025 · 1 citations
  5. 5Multiple myeloma in the real world settings: prognostic significance of 1q21 chromosomal abnormalities - single center experience2026